key: cord-0746910-lcsstjbb
authors: Eichenberger, Emily M.; Kaul, Daniel R.; Wolfe, Cameron R.
title: The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors
date: 2021-10-06
journal: Transpl Infect Dis
DOI: 10.1111/tid.13727
sha: fec0ff97a392d8ac0e5cdb0eacae19c51dae82da
doc_id: 746910
cord_uid: lcsstjbb

nan

positive donors.

To date, three cases of donor derived COVID-19 infection have been reported, each occurring in lung transplant recipients 6, 7 (personal communication). In each of these cases, the donor had a negative COVID-19 nasopharyngeal swab at the time of organ procurement, but was later found to have SARS-CoV-2 on bronchoalveolar lavage. All three recipients developed critical COVID-19 infection, and one died. 6 ing disease. There is now an emergency use authorization approving emergency use of casirivimab and imdevimab for post exposure prophylaxis for COVID-19. 10 We need to establish whether there is a role for preemptively boosting the humoral response with a long acting monoclonal antibody at the time of transplant. Once again, understanding if viable virus is present in the transplanted organ would help guide clinicians on the need for antiviral or antibody therapy posttransplant.

In conclusion, the use of extra-pulmonary organs from COVIDpositive donors may present a viable pathway to transplant for selected patients who would benefit from an expanded donor pool.

More data are urgently needed, especially as we face resurgent cases of the delta variant, in order to establish the safety of this practice.

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Emily M. Eichenberger 1 Daniel R. Kaul 2 Cameron R. Wolfe 1

Kidney transplantation from a SARS-CoV-2-positive donor for the recipients with immunity after COVID-19

A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: ongoing dilemma between discarding and accepting organs in COVID-19 era!

Heart and liver transplant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation

Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors?

Successful heart and kidney transplantation from a deceased donor with PCR positive COVID-19

Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing

A call to routinely test lower respiratory tract samples for SARS-CoV-2 in lung donors

Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study

Ten years of donor-derived disease: a report of the disease transmission advisory committee

FDA authorizes REGEN-COV monoclonal antibody therapy for postexposure prophylaxis (prevention) for COVID-19. FDA

Early success transplanting kidneys from donors with new SARS-CoV-2 RNA positivity: a report of 10 cases

A case of coronavirus disease 2019-infected liver transplant donor

Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor

Successful transplantation of organs from a deceased donor with early SARS-CoV-2 infection

Is kidney transplantation from a COVID-19-positive deceased donor safe for the recipient?

Transplant of SARS-CoV-2-infected living donor liver: case report